Over 12 months, Alx Oncology Holdings Inc saw more buying than selling from its insiders — purchases of about $5 million against sales of $43,000.
GOODMAN COREY S (Director) made the biggest buy, worth around $5 million.
Zooming out by quarter: Last full quarter: net selling by insiders. Insiders bought in 2 of the last 7 full quarters. On the institutional side, 94 funds reported holding ALXO at the end of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Lettmann Jason | CEO | Sell | 2,230 | $1.93 | $4K | SEC |
| Aug 18, 2026 | Wong Shelly | Executive Officer | Sell | 573 | $1.93 | $1K | SEC |
| Jul 6, 2026 | Wong Shelly | Executive Officer | Sell | 1,404 | $2.04 | $3K | SEC |
| Mar 23, 2026 | Lettmann Jason | CEO | Sell | 12,311 | $2.17 | $27K | SEC |
| Mar 23, 2026 | Pinto Shelly | Executive Officer | Sell | 903 | $2.17 | $2K | SEC |
| Feb 20, 2026 | Pinto Shelly | Executive Officer | Sell | 565 | $2.27 | $1K | SEC |
| Feb 4, 2026 | GOODMAN COREY S | Director | Buy | 3,184,713 | $1.57 | $5.0M | SEC |
| Jan 7, 2026 | Pinto Shelly | Executive Officer | Sell | 3,925 | $1.11 | $4K | SEC |
| Sep 18, 2025 | Lettmann Jason | CEO | Buy | 71,163 | $1.08 | $77K | SEC |
| Sep 18, 2025 | Lettmann Jason | CEO | Buy | 21,070 | $1.07 | $23K | SEC |
| Aug 20, 2025 | Shantharam Harish | CFO | Buy | 75,000 | $0.78 | $58K | SEC |
| Aug 19, 2025 | Pinto Shelly | Executive Officer | Sell | 611 | $0.64 | $391 | SEC |
| Aug 19, 2025 | Lettmann Jason | CEO | Sell | 2,382 | $0.64 | $2K | SEC |
| Jul 8, 2025 | Pinto Shelly | Executive Officer | Sell | 2,011 | $0.45 | $905 | SEC |
| Jul 1, 2025 | Pinto Shelly | Executive Officer | Sell | 1,532 | $0.43 | $659 | SEC |
In the last 12 months Alx Oncology Holdings Inc insiders made open-market purchases worth about $5 million and sales worth about $43,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in ALXO was filed on 2026-08-18.
94 investment managers reported holding ALXO in SEC Form 13F filings for Q2 2026.
No congressional trades in ALXO were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).